All Roll Calls
Yes: 179 • No: 49
Sponsored By: Steve Vetter (Republican)
Became Law
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
5 provisions identified: 1 benefits, 2 costs, 2 mixed.
Manufacturing facilities must get state approval before making edible cannabinoid products. Dispensaries must get approval before they possess, market, or sell these products. The department reviews and approves the form, manufacturing, packaging, labeling, and marketing. Edibles must be made in a department‑licensed commercial kitchen that is inspected each year. The department must also set rules for these standards and to prohibit marketing to minors.
Each edible serving is limited to 10 mg of THC. Each capsule and each transdermal patch is capped at 50 mg of THC per serving. Topical products may not exceed 6% THC. Liquid solutions must be in containers no larger than 30 milliliters.
Registered patients or their registered caregivers can buy up to 2.5 ounces of dried cannabis in any 30 days. With an enhanced registry ID card, the 30‑day purchase limit is 6 ounces. You may possess up to 3 ounces of dried cannabis at any time, or 7.5 ounces with an enhanced card. Across concentrates and medical cannabinoid products, you can get no more than 6,000 mg of THC in 30 days. For edibles, you may possess up to 500 mg of edible product and no more than 310 mg of THC in edible form at any time.
Edible packages must be resealable, child‑resistant, and not see‑through. Each package can have at most 100 mg of THC. Labels must use black Arial text and show the name, maker, ingredients, THC per serving, and servings per package. Marketing that targets people under 18 is banned.
Pediatric medical marijuana must include cannabidiol and cannot have more than 6% THC. When the registered patient is a minor, usable marijuana is limited to pediatric medical marijuana. The law also says cannabinoid edible products do not count as “usable marijuana.”
Steve Vetter
Republican • House
Landon Bahl
Republican • House
Nels Christianson
Republican • House
Josh Christy
Republican • House
Gretchen Dobervich
Democratic • House
Kathy Frelich
Republican • House
Matthew Ruby
Republican • House
Vicky Steiner
Republican • House
Claire Cory
Republican • Senate
Scott Meyer
Republican • Senate
All Roll Calls
Yes: 179 • No: 49
House vote • 4/15/2025
Second reading, passed, yeas 70 nays 21
Yes: 70 • No: 21
Senate vote • 4/4/2025
Second reading, passed as amended, yeas 42 nays 3
Yes: 42 • No: 3
House vote • 2/4/2025
Second reading, passed, yeas 67 nays 25
Yes: 67 • No: 25
Filed with Secretary Of State 04/22
Signed by Governor 04/21
Sent to Governor
Signed by Speaker
Signed by President
Second reading, passed, yeas 70 nays 21
Concurred
Returned to House (12)
Second reading, passed as amended, yeas 42 nays 3
Amendment adopted, placed on calendar
Reported back amended, do pass, amendment placed on calendar 5 1 0
Committee Hearing 01:30
Introduced, first reading, referred Human Services Committee
Received from House
Second reading, passed, yeas 67 nays 25
Laid over one legislative day
Amendment adopted, placed on calendar
Reported back amended, do pass, amendment placed on calendar 12 0 1
Committee Hearing 03:30
Introduced, first reading, referred Human Services Committee
Adopted by the House Human Services Committee
Adopted by the Senate Human Services Committee
Enrollment
FIRST ENGROSSMENT
FIRST ENGROSSMENT with Senate Amendments
INTRODUCED
HB 1022 — AN ACT to provide an appropriation for defraying the expenses of the retirement and investment office.
SB 2018 — AN ACT to provide an appropriation for defraying the expenses of the department of commerce; to provide an appropriation to the attorney general; to provide an appropriation to the department of career and technical education; to provide an appropriation to the state fair association; to provide a contingent appropriation; to create and enact a new section to chapter 54-60 of the North Dakota Century Code, relating to department of commerce grant reporting requirements; to amend and reenact subsection 1 of section 10-30.5-02, sections 54-60-09, 54-60-19, 54-60-28, 54-60-29, 54-60-29.1, and 54-60-31 of the North Dakota Century Code, relating to the purpose of the North Dakota development fund, duties and talent strategy of the division of workforce development, the uncrewed aircraft systems program, the uncrewed aircraft systems program fund, the beyond visual line of sight uncrewed aircraft system program, and changing the name of the office of legal immigration to the global talent office; to authorize a Bank of North Dakota line of credit; to provide for a transfer; to provide an application; to provide an exemption; and to provide for a legislative management report.
SB 2323 — AN ACT to amend and reenact sections 57-51-15 and 57-51.1-07.5 of the North Dakota Century Code, relating to oil and gas gross production tax allocations and the state share of oil and gas tax allocations; to provide for a legislative management report; to provide an exemption; and to provide an effective date.
SB 2390 — AN ACT to create and enact three new sections to chapter 54-40.1 of the North Dakota Century Code, relating to a rural catalyst committee, grant program, and fund; to amend and reenact section 54-40.1-02 of the North Dakota Century Code, relating to definitions for regional planning councils; to provide an appropriation; and to provide for a transfer.
SB 2397 — AN ACT to create and enact a new subsection to section 57-51.1-03 of the North Dakota Century Code, relating to a limited exemption for development incentive wells; to amend and reenact sections 57-51-02.6, 57-51-05, and 57-51.1-01 of the North Dakota Century Code, relating to the temporary exemption for oil and gas wells employing a system to avoid flaring, an exemption from gross production tax for gas produced from certain enhanced oil recovery projects, and the definition of development incentive well; to provide an effective date; and to provide an expiration date.
SB 2370 — AN ACT to provide for a legislative management study regarding prescription drug transparency reporting under the federal drug discount program.